Logo image of MOSY

MOSYS INC (MOSY) Stock Fundamental Analysis

NASDAQ:MOSY - Nasdaq - US6197181091 - Common Stock

4.5  +0.29 (+6.89%)

Fundamental Rating

2

Overall MOSY gets a fundamental rating of 2 out of 10. We evaluated MOSY against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. While MOSY seems to be doing ok healthwise, there are quite some concerns on its profitability. MOSY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MOSY has reported negative net income.
MOSY Yearly Net Income VS EBIT VS OCF VS FCFMOSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -22.08%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MOSY Yearly ROA, ROE, ROICMOSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 -50 -100 -150 -200

1.3 Margins

Industry RankSector Rank
OM -107.49%
PM (TTM) -97.69%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MOSY Yearly Profit, Operating, Gross MarginsMOSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, MOSY has more shares outstanding
Compared to 1 year ago, MOSY has a worse debt to assets ratio.
MOSY Yearly Shares OutstandingMOSY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 1M 2M 3M
MOSY Yearly Total Debt VS Total AssetsMOSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

2.2 Solvency

MOSY has an Altman-Z score of -2.38. This is a bad value and indicates that MOSY is not financially healthy and even has some risk of bankruptcy.
There is no outstanding debt for MOSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.38
ROIC/WACCN/A
WACCN/A
MOSY Yearly LT Debt VS Equity VS FCFMOSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 20M -20M 40M

2.3 Liquidity

MOSY has a Current Ratio of 10.16. This indicates that MOSY is financially healthy and has no problem in meeting its short term obligations.
MOSY has a Quick Ratio of 9.59. This indicates that MOSY is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 10.16
Quick Ratio 9.59
MOSY Yearly Current Assets VS Current LiabilitesMOSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 5M 10M 15M 20M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.73% over the past year.
Looking at the last year, MOSY shows a very negative growth in Revenue. The Revenue has decreased by -27.30% in the last year.
MOSY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.15% yearly.
EPS 1Y (TTM)28.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.22%
Revenue 1Y (TTM)-27.3%
Revenue growth 3Y-8.37%
Revenue growth 5Y9.15%
Sales Q2Q%-32.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
MOSY is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -40.34% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-64.73%
Revenue Next 2Y-40.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MOSY Yearly Revenue VS EstimatesMOSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
MOSY Yearly EPS VS EstimatesMOSY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 0 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MOSY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MOSY Price Earnings VS Forward Price EarningsMOSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -3.63
MOSY Per share dataMOSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MOSY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOSYS INC

NASDAQ:MOSY (12/17/2021, 9:18:44 PM)

4.5

+0.29 (+6.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.46%
Inst Owner Change0%
Ins Owners21.08%
Ins Owner Change0%
Market Cap39.04M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.17
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB N/A
EV/EBITDA -3.63
EPS(TTM)-0.98
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.63
BVpS2.54
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -107.49%
PM (TTM) -97.69%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.16
Quick Ratio 9.59
Altman-Z -2.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.3%
Revenue growth 3Y-8.37%
Revenue growth 5Y9.15%
Sales Q2Q%-32.13%
Revenue Next Year-64.73%
Revenue Next 2Y-40.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A